Inflammation and cardiovascular risk in dialysis patients. terol are reduced [3]. The modulation of the balance Background. Chronic inflammation, as evidenced by inbetween atherogenic proteins, also called emerging new creased levels of C-reactive protein (CRP), predicts all-cause risk factors or non-traditional risk factors, and antiathand cardiovascular mortality in hemodialysis patients in shorterogenic proteins may explain the progressive nature of term studies. Whether CRP is also predictive in the long-term atherosclerosis in the absence of classic, traditional risk follow-up is unknown. Methods. We conducted a 4-year follow-up of a cross-secfactors in dialysis patients. Because the levels of these tional study in a cohort of 280 stable hemodialysis patients. proteins might undergo continuous modulation [6] by CRP was determined once at the beginning of the study, and the acute phase stimuli, it remains unclear for what periall-cause as well as cardiovascular mortality was monitored proods of time these proteins remain predictive in hemodispectively. Results. During follow-up, 123 patients (43.9%) had died,
In the present study, we therefore evaluated the 4-year annual mortality rate of 11%. Overall mortality and cardiovaspredictive power of acute phase proteins and its best cular mortality were significantly higher in patients with a CRP known representative, CRP, in a cohort of 280 hemodimore than 8 mg/L (73% vs. 39% and 87% vs. 55%, respectively).
alysis patients.
Multivariate Cox regression analysis demonstrated that age, CRP, and preexisting cardiovascular disease were the most powerful predictors, but the presence of diabetes, albumin, and BMI also remained in the model.
METHODS

Conclusion. A single determination of CRP is a powerful in-
The study population, baseline examination, sampling dicator of all cause and cardiovascular death even after a folprocedure, and laboratory analysis as well as statistical low-up period of 4 years in patients on hemodialysis treatment. analysis have been described previously [3] . Briefly, between September and November 1995, patients from three outpatient dialysis centers entered the study (130 The inflammatory response to a given stimulus can be women and 150 men, mean age 62.4 Ϯ 13.7 yrs). Patients evidenced by a number of acute phase proteins; the most were already on hemodialysis treatment for 55 Ϯ 56 established is C-reactive protein (CRP) [1] . CRP is a months. A follow-up investigation was performed at 12, prominent product of the inflammatory response syn-24, and 48 months, and the results of the latter evaluation drome and a marker of overall and cardiovascular death are reported here. Data from all original 280 hemodialyin the general population as well as in hemodialysis patients [2] [3] [4] . CRP is elevated 8-10-fold in hemodialysis sis patients could be obtained for analysis of the fourpatients as compared with healthy controls [3] [4] [5] and
year mortality, and no patient was lost in the follow-up. appears to be a common feature in chronic renal failure Date and cause of death were evaluated from records and dialysis patients. Chronic inflammation is linked to and from interviews with the physicans in the outpatient atherosclerotic cardiovascular disease by a number of dialysis centers. Causes of death were classified as demechanisms and contributes to the high mortality seen scribed previously [3] . in this patient group. Chronic inflammation is accompanied by an increase in serum levels of other important RESULTS acute phase proteins such as fibrinogen and lipoprotein(a) which also are atherogenic. On the other hand, levels of
The data of the two-year analysis have been reported anti-atherogenic proteins such as apolipoprotein A-I previously [3] . During the follow-up period of four years, (ApoA-I) and high density lipoprotein (HDL) choles-123 out of 280 patients (44%) had died, most from cardiovascular events (72 out of 123, 58%), corresponding to an annual mortality rate of 11%. The death rate curve was linear. Patients with diabetes (N ϭ 81) had a higher mortality rate at 4 years (65%) as compared with patients  2002 by the International Society of Nephrology S-99
S-100
higher risk for cardiovascular mortality (87 vs. 50%; P Ͻ 0.0001) during follow-up than those in the lowest quartile (less than 3.3 mg/L). Tables 1 and 2 outline univariate and multivariate stepwise logistic regression process by the Cox proportional hazards method.
DISCUSSION
This study confirms that inflammation is associated with an increased overall and cardiovascular mortality in hemodialysis patients and adds data that prediction is even maintained after prolonged periods of observation. It is puzzling and still unresolved how a single and cross-sectional obtained level of a plasma protein with a short half life (19 h) may yield such important information concerning the long-term prognosis in hemodialysis patients. Many centers today measure CRP on a routine basis but no further data are yet available that add knowledge. Pankow et al investigated familial aggregation of CRP in a large, cross-sectional study conducted in four US communities. The found a substantial heritability (35-40%) for CRP levels suggesting that genetic factors determine, at least in part, a given basal CRP level in serum [7] . Opinions have been brought forward to use the mean of multiple measurement, or the delta of two subsequent measurements, or even the area under the curve of several measurements. Further studies must show whether these approaches are superior to a single measurement in a given patient without infection.
Vascular disease and the predictive value of CRP in dialysis patients
Apparently we may see exactly the same thing in uremic patients that we see in healthy subjects, only at a higher level of expression and in a shorter period of time. CRP measured years before the acute event independently predicts future risk [3, 4, 8] . In addition, CRP levels are also associated with an increased intima-media carotid artery area in predialysis patients [9] . Other negative and positive acute phase reactants, such as albumin, fibrinogen, ApoA-I, and lipoprotein(a) correlate with cular risk [3, 4, 10] . Because CRP is largely regulated by circulating levels of interleukin-6 (IL-6), it can be understood that this cytokine itself predicts mortality in without diabetes (33%). The relative risk of death in hemodialysis patients and in otherwise healthy elderly general as well as death caused by cardiovascular events men and women [11] [12] [13] . increased with each quartile of baseline concentrations Causes of the chronic inflammatory state in dialysis of CRP. Figure 1 demonstrates Kaplan-Meier estimates patients. CRP may reflect the consequences of elevated of survival during follow-up with regard to all-cause (A) levels of proinflammatory cytokines. Several interleukins and cardiovascular mortality (B) in relation to quartiles are known mediators of the acute phase response. Tumor of CRP serum concentrations. Patients in the highest necrosis factor-␣ (TNF-␣) or IL-1 isoforms can stimulate quartile (more than 15.8 mg/L) had a 2.4-fold higher risk the expression of IL-6 provoking the augmented expression of the CRP gene in the liver. The rate of hepatic (83 vs. 34%; P Ͻ 0.0001) for all-cause and a 1.7-fold Abbreviations are: 2 , the chi-square statistic; BMI, body mass index; CRP, C-reactive protein; CVD, cardiovascular disease. synthesis of CRP is the sole determinant of its plasma the patients [5, 16] . Lipopolysaccharide, through dialysate contamination, may stimulate cells to secrete cyto-concentration. But which signal has stimulated endothelial cells, monocytes, T-lymphocytes, or mast cells to kines and to initiate an inflammatory reaction. Indeed, a recent work of Sitter et al [17] suggests that the use secrete these mediators? We do not yet know, but most likely enhanced formation of oxygen-free-radicals are of ultrapure dialysis solution will lower plasma CRP in dialysis patients as compared with conventional dialysis. involved or have a well defined place in this cascade. To clarify this issue, an intense search for endogenous as
The vascular access or the hemodialysis membrane itself may also be candidates to maintain chronic stimulation well as exogenous factors is currently under way. Since patients with chronic renal failure, not yet on mainte-of CRP. The presence of an arteriovenous graft is a significant predictor, associated with high CRP and reduced nance hemodialysis, or continuous arterial peritoneal dialysis (CAPD) patients exhibit a similar degree of eleva-albumin [6] . Schindler et al [5] investigated the impact of hemodialysis using cuprophane, polyamide, and poly-tion in CRP levels [9] , probably factors unrelated to the hemodialysis procedure but more related to accumula-carbonate membranes in a crossover design on serum levels of IL-1 receptor antagonist and CRP in 18 patients. tion of toxins are more likely to play the predominant role. In peritoneal dialysis (PD) patients, peritoneal Dialysis with cuprophane significantly stimulated the acute phase response as compared with the more bio-transport rate during the first year of treatment is linked with inflammation and declining RRF. It is possible that compatible membranes. Does oxidative stress cause inflammation? Compelling inflammation may cause both an increase in peritoneal transport rate and a decline in RRF, or that the decline evidence now exists that dialysis patients are exposed to enhanced oxidative stress. Oxidative stress is initiated in RRF further aggravates inflammation because of less efficient removal of cytokines [14] . Further studies by the generation of oxygen free radicals, mainly in tissue and probably in the circulation. The most potent and so should investigate at what stages of declining renal function the cascade of inflammation is turned on. These far best investigated O 2 -generating proteins are oxidatively modified lipoproteins, mainly oxidized (ox)-LDL. studies should be designed in order to control for a maximum of confounding factors, and they should include A similar and comparable inflammatory milieu may be created by advanced glycation and oxidaton end products repeated measurements during a longitudinal follow-up. Most ideally, the intervention of a potent antioxidant (AGEs, AOPPs). Both molecules, oxLDL and AGEs may be potent stimulators of oxygen-free radicals via such as an ACE-inhibitor or a statin is appreciated [15] .
It has been proposed that the dialysis procedure per an NADP/NADPH-dependent process. Oxidative and carbonyl stress may stimulate cells and the endothelium se may be responsible for the inflammatory reaction in
